Skip to main content

Home/ Technology/ Group items tagged breast

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
1More

Global Breast Pumps Market to Grow at a CAGR of 7.2% and to Reach US$ 1445.0 Million by... - 0 views

www.healthgazette24.com/...10852 Size Analysis Trends Forecasts Overview Growth Share Research Business Reports pumps market breast
shared by xaralite on 22 Aug 19 - No Cached
  • xaralite on 22 Aug 19
     
    The global breast pump market is estimated to reach a market value of US$ 830.4 million in 2019 and is forecast to reach US$ 1445.0 million by 2027, growing at an estimated CAGR of 7.2% over the forecast period.
1More

ESMO 2019: Kisqali shows superior overall survival in breast cancer - 1 views

www.clinicaltrialsarena.com/...esmo-novartis-kisqali #ESMO_2019 #esmo_conference_2019 #esmo_congress_2019 #Breast_Cancer #esmo_2019_dates
shared by jacob logan on 07 Oct 19 - No Cached
  • jacob logan on 07 Oct 19
     
    Novartis has said that Kisqali delivered superior overall survival (OS) in the Monaleesa-3 trial, demonstrating more life for postmenopausal human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer patients.
1More

ESMO 2019: Merck unveils neoadjuvant/adjuvant TNBC trial results - 1 views

www.clinicaltrialsarena.com/...nt-adjuvant-tnbc-trial-results #esmo_2019 #Samsung_Bioepis_reveals #esmo_2019_dates #Bevacizumab #biosimilar_trial_result #non_small_cell_lung_cancer.
shared by jacob logan on 04 Oct 19 - No Cached
  • jacob logan on 04 Oct 19
     
    A regimen of neoadjuvant Keytruda and chemotherapy extended pathological complete response (pCR) rates by 13.6% compared to chemotherapy alone in patients with early triple-negative breast cancer (TNBC), according to findings from the Phase III Keynote-522 study presented at the ESMO Congress 2019.
1 - 3 of 3
Showing 20▼ items per page